Savara Pharmaceuticals
SVRA
#6618
Rank
NZ$0.96 B
Marketcap
$5.62
Share price
-1.23%
Change (1 day)
-24.15%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -NZ$0.14 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$95.44 Million a decrease over its 2022 earnings that were of -NZ$66.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.14 Billion40.68%
2023 -NZ$95.44 Million43.38%
2022 -NZ$66.57 Million-11.31%
2021 -NZ$75.06 Million-13.3%
2020 -NZ$86.57 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.12 Billion105.54%
2017 -NZ$58.34 Million34.11%
2016 -NZ$43.5 Million-37.43%
2015 -NZ$69.52 Million38.81%
2014 -NZ$50.08 Million33.62%
2013 -NZ$37.48 Million38.49%
2012 -NZ$27.07 Million24.59%
2011 -NZ$21.73 Million-36.5%
2010 -NZ$34.21 Million-3.14%
2009 -NZ$35.32 Million-23.28%
2008 -NZ$46.04 Million8.52%
2007 -NZ$42.42 Million-34.14%
2006 -NZ$64.41 Million184.43%
2005 -NZ$22.65 Million90.75%
2004 -NZ$11.88 Million190.35%
2003 -NZ$4.09 Million11.64%
2002 -NZ$3.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$31.68 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA